Skip to main content

Madrigal Pharmaceuticals, Inc.

MDGL
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001157601

In the last 90 days, Madrigal Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 3 sales; 414 institutions reported holding it in 13F filings for Q2 2026, worth $12.7B in total; no superinvestor holds it.

Q4 2024 vs. Q3 2024

How the institutions holding Madrigal Pharmaceuticals, Inc. changed between Q3 2024 and Q4 2024.

All holders in Q4 2024All holders in Q3 2024

13F holders of MDGL: Q3 2024 compared with Q4 2024
MeasureQ3 2024Of which not filed for Q4 2024Q4 2024Change
Holders2574283+30
Shares22.7M52.9K23.0M+334.5K (+1.5%)
Value$4.77B$15.7M$7.08B+$2.32B (+48.8%)

4 institutions that held it in Q3 2024 haven't filed for Q4 2024 yet. Not filing isn't selling, so the changes leave them out.

New holders (67)

Institutions that held Madrigal Pharmaceuticals, Inc. at the end of Q4 2024 but not at the end of Q3 2024.

Institutions new to MDGL in Q4 2024
InstitutionSharesValue% of portfolio
William Blair Investment Management, LLC371,771$114.7M0.28%
Hood River Capital Management LLC127,839$39.4M0.58%
Siren, L.L.C.125,942$38.9M1.72%
Raymond James Financial Inc53,846$16.6M0.01%
Lord, Abbett & Co. LLC48,917$15.1M0.05%
D. E. Shaw & Co., Inc.23,844$7.36M0.01%
Neuberger Berman Group LLC22,128$6.83M0.01%
Adage Capital Partners GP, L.L.C.19,960$6.16M0.01%
Aquatic Capital Management LLC15,032$4.64M0.13%
Kornitzer Capital Management Inc14,760$4.55M0.09%
Balyasny Asset Management LLC14,228$4.39M0.01%
Canada Pension Plan Investment Board13,400$4.13M0.00%
Soleus Capital Management, L.P.10,900$3.36M0.25%
Tudor Investment Corp Et Al10,327$3.19M0.03%
Algert Global LLC9,770$3.01M0.07%
Twin Tree Management, LP9,738$3.00M0.07%
Man Group plc8,498$2.62M0.01%
Newbridge Financial Services Group, Inc.4,203$1.30M0.33%
Police & Firemen's Retirement System of New Jersey3,881$1.20M0.01%
Landscape Capital Management, L.L.C.3,624$1.12M0.12%
Tema ETFs LLC3,620$1.12M0.46%
Carrera Capital Advisors3,243$1.00M0.23%
Los Angeles Capital Management LLC2,752$849.2K0.00%
KLP Kapitalforvaltning AS2,600$802.3K0.00%
PEAK6 LLC2,300$709.7K0.03%
F/M Investments LLC2,259$697.1K0.03%
Bryce Point Capital, LLC1,903$587.2K0.17%
Aigen Investment Management, LP1,771$546.5K0.10%
CIBC World Markets Corp1,681$518.7K0.00%
Squarepoint Ops LLC1,548$477.7K0.00%
Cerity Partners LLC1,467$407.6K0.00%
Dark Forest Capital Management LP1,286$396.8K0.06%
Capula Management Ltd1,148$354.2K0.00%
Superstring Capital Management LP1,129$348.4K0.31%
FORA Capital, LLC1,123$346.5K0.04%
Bridgefront Capital, LLC1,084$334.5K0.11%
Rossby Financial, LCC1,048$323.4K0.21%
Syon Capital LLC1,014$312.9K0.03%
Brevan Howard Capital Management LP1,001$308.9K0.01%
683 Capital Management, LLC1,000$308.6K0.03%
Exome Asset Management LLC987$304.6K0.23%
Kazazian Asset Management, LLC950$293.1K0.23%
Dorsey & Whitney Trust CO LLC834$257.3K0.01%
JustInvest LLC790$243.8K0.00%
Atria Investments LLC720$222.2K0.00%
Campbell & CO Investment Adviser LLC718$221.6K0.02%
D.A. Davidson & Co.715$220.6K0.00%
Miracle Mile Advisors, LLC700$216.0K0.00%
Farringdon Capital, Ltd.697$215.1K0.09%
Jump Financial, LLC682$210.4K0.00%
Wealth Enhancement Advisory Services, LLC680$209.8K0.00%
Graham Capital Management, L.P.659$203.3K0.01%
BI Asset Management Fondsmaeglerselskab A/S531$164.0K0.00%
GF Fund Management Co. Ltd.458$141.3K0.00%
Kohmann Bosshard Financial Services, LLC228$70.4K0.01%
Caitong International Asset Management Co., Ltd106$32.7K0.03%
SBI Securities Co., Ltd.70$21.6K0.00%
Aventura Private Wealth, LLC62$19.1K0.01%
Bayforest Capital Ltd46$14.2K0.02%
Bradley & Co. Private Wealth Management, LLC27$8.33K0.01%
Skopos Labs, Inc.14$4.32K0.00%
CBIZ Investment Advisory Services, LLC8$2.47K0.00%
Meeder Asset Management Inc7$2.16K0.00%
MAI Capital Management4$1.24K0.00%
Northwestern Mutual Wealth Management Co4$1.23K0.00%
Riverview Trust Co2$6170.00%
Tucker Asset Management LLC1$3090.00%

Sold out (37)

Institutions that held Madrigal Pharmaceuticals, Inc. at the end of Q3 2024 and filed for Q4 2024 without it.

Not filed for Q4 2024 yet (4)

Institutions that held Madrigal Pharmaceuticals, Inc. at the end of Q3 2024 and haven't filed a 13F for Q4 2024. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding MDGL in Q3 2024 that haven't filed for Q4 2024
InstitutionShares, Q3 2024Value, Q3 2024
Eagle Asset Management Inc32,396$11.4M
Raymond James & Associates19,433$4.12M
Sweet Financial Partners, LLC1,000$212.2K
PEAK6 Investments LLC27$5.73K